Anti-EBV Latent Membrane Protein 1 antibody [CS1, CS2, CS3, CS4], prediluted
Be the first to review this product! Submit a review
|
(3 Publications)
Mouse Monoclonal EBV Latent Membrane Protein 1 antibody. Carrier free. Suitable for IHC-Fr, IHC-P and reacts with Epstein-Barr virus samples. Cited in 3 publications.
View Alternative Names
BNLF1, LMP1, Latent membrane protein 1, LMP-1, Protein p63
- IHC-P
AbReview
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EBV Latent Membrane Protein 1 antibody [CS1, CS2, CS3, CS4], prediluted (AB7502)
The image shows lung tissue diagnosed with Post-Transplantation Lymphoproliferative Disorder (PTLD). Mononuclear cells are stained brown with DAB chromogen around the cytoplasm - typical for Latent Membrane Protein-1 of EBV.
This picture was kindly supplied as part of the review submitted by Pradeep Rai.
Reactivity data
Properties and storage information
Form
Purity
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein plays a role in cellular transformation and proliferation acting as a mimic of CD40 receptor signaling. Within cells LMP1 aggregates to form oligomeric complexes that actively recruit TRAF and TRADD adapter proteins. This aggregation leads to the activation of NF-κB signaling and the MAPK pathways contributing to increased cell survival and proliferation. LMP1 functions as a major factor in sustaining EBV latency in infected cells and is essential for the virus's oncogenic potential.
Pathways
LMP1 is an integral component of the NF-κB and AP-1 signaling pathways. By engaging with the host cell machinery LMP1 recruits proteins such as IκB kinase complexes leading to the nuclear translocation of NF-κB transcription factors. This results in the transcription of genes related to cell growth and inflammation. LMP1 also interacts with p38 MAPK further enhancing pathways that contribute to EBV’s ability to foster an environment suitable for its persistence and propagation within the host.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:3905 PubMed40280928
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 16:e1008590 PubMed32542010
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 91: PubMed28179525
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com